arrow
C

Catherine Le Berre

Icahn School of Medicine at Mount Sinai
H指数:22
被引数:5,420

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy

与BCMA car-t细胞治疗相关的小肠结肠炎中粘膜car-t细胞的持久性和炎症重塑

2026-09-230
PRE
Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID

炎症性肠病患者肠道急迫感、疾病活动度与残疾的相关性:一项来自GETAID的横断面研究

2026-08-010
PRE
Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease

炎症性肠病患者体力活动与疾病活动及功能障碍的关系

2026-02-030
OAAI
Early symptomatic improvement with obefazimod in patients with moderately to severely active ulcerative colitis: pooled results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials

奥贝非齐模德治疗中重度活动性溃疡性结肠炎患者的早期症状改善:ABTECT-1和ABTECT-2两项III期、双盲、安慰剂对照诱导试验的合并结果

2026-01-010
PRE
One-Year Effectiveness and Safety of Upadacitinib in 261 Patients With Crohn's Disease: A Multicenter Real-World Cohort Study

乌帕替尼在261例克罗恩病患者中的一年有效性与安全性:一项多中心真实世界队列研究

2026-01-010
PRE
Comparison of effectiveness between subcutaneous infliximab as monotherapy or combined with an immunosuppressant in patients with Crohn's disease: interim results from the REMONO-CD study.

比较皮下注射英夫利昔单抗作为单药治疗或与免疫抑制剂联用对克罗恩病患者的疗效:REMONO-CD研究的初步结果

2026-01-010
PRE
Factors Associated with a Complicated Behavior or Diagnostic Delay in Crohn's Disease: A Prospective Multicenter French and Belgian Cohort of Newly Diagnosed Patients

克罗恩病患者复杂行为或诊断延迟的相关因素:一项法国和比利时多中心前瞻性新诊断患者队列研究

2026-01-010
PRE
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID

皮下注射维多利珠单抗剂量强化在炎症性肠病患者中的应用:GETAID组织的OPTI-VEDO多中心研究

2025-09-010
PRE
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis

托法替布与乌帕替尼治疗急性重度溃疡性结肠炎的疗效比较

2025-07-260
OAAI
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study

乌帕替尼诱导治疗223例克罗恩病患者的有效性与安全性:一项GETAID多中心队列研究

2025-03-042
OAAI